NL8403307A - Furylderivaten van op plaats 16 gesubstitueerde prostaglandinen, werkwijze ter bereiding daarvan, alsmede farmaceutisch of veterinair preparaat, dat dergelijke derivaten bevat. - Google Patents

Furylderivaten van op plaats 16 gesubstitueerde prostaglandinen, werkwijze ter bereiding daarvan, alsmede farmaceutisch of veterinair preparaat, dat dergelijke derivaten bevat. Download PDF

Info

Publication number
NL8403307A
NL8403307A NL8403307A NL8403307A NL8403307A NL 8403307 A NL8403307 A NL 8403307A NL 8403307 A NL8403307 A NL 8403307A NL 8403307 A NL8403307 A NL 8403307A NL 8403307 A NL8403307 A NL 8403307A
Authority
NL
Netherlands
Prior art keywords
furyl
methyl
compound
formula
trinor
Prior art date
Application number
NL8403307A
Other languages
English (en)
Dutch (nl)
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of NL8403307A publication Critical patent/NL8403307A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
NL8403307A 1983-11-04 1984-10-31 Furylderivaten van op plaats 16 gesubstitueerde prostaglandinen, werkwijze ter bereiding daarvan, alsmede farmaceutisch of veterinair preparaat, dat dergelijke derivaten bevat. NL8403307A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838329559A GB8329559D0 (en) 1983-11-04 1983-11-04 Furyl derivatives of 16-substituted prostaglandins preparations
GB8329559 1983-11-04

Publications (1)

Publication Number Publication Date
NL8403307A true NL8403307A (nl) 1985-06-03

Family

ID=10551287

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8403307A NL8403307A (nl) 1983-11-04 1984-10-31 Furylderivaten van op plaats 16 gesubstitueerde prostaglandinen, werkwijze ter bereiding daarvan, alsmede farmaceutisch of veterinair preparaat, dat dergelijke derivaten bevat.

Country Status (18)

Country Link
US (1) US4585791A (da)
JP (1) JPS60112782A (da)
AU (1) AU563999B2 (da)
BE (1) BE900959A (da)
CH (1) CH663413A5 (da)
DE (1) DE3439863A1 (da)
DK (1) DK524484A (da)
FI (1) FI844273L (da)
FR (1) FR2554448B1 (da)
GB (2) GB8329559D0 (da)
GR (1) GR80822B (da)
HU (1) HU193708B (da)
IL (1) IL73395A0 (da)
IT (1) IT1177095B (da)
NL (1) NL8403307A (da)
SE (1) SE8405514L (da)
SU (1) SU1489582A3 (da)
ZA (1) ZA848551B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834498A (en) * 1992-09-21 1998-11-10 Allergan Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5741810A (en) * 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
US8063033B2 (en) * 2008-01-18 2011-11-22 Allergan, Inc. Therapeutic beta-lactams
US7960378B2 (en) 2008-03-18 2011-06-14 Allergan, Inc. Therapeutic compounds
US7803797B2 (en) 2008-04-24 2010-09-28 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
EP2297084A1 (en) * 2008-04-24 2011-03-23 Allergan, Inc. Therapeutic compounds
US7981887B2 (en) 2008-05-09 2011-07-19 Allergan, Inc. Therapeutic compounds
WO2009137412A1 (en) * 2008-05-09 2009-11-12 Allergan, Inc. Therapeutic compounds
CA2728227A1 (en) * 2008-05-09 2009-11-12 Allergan, Inc. Therapeutic cyclopentane derivatives
US7713967B2 (en) * 2008-05-09 2010-05-11 Allergan, Inc. Therapeutic substituted hydantoins, and related compounds
CN106748951B (zh) 2012-07-19 2020-07-24 开曼化学股份有限公司 作为在治疗ep4介导的疾病和病状中使用的ep4受体选择性激动剂的二氟内酰胺化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
ES416865A1 (es) * 1972-07-13 1976-03-01 Pfizer Procedimiento para preparar w-pentanorprostaglandinas sus- tituidas en la posicion 15.
US3956284A (en) * 1972-07-13 1976-05-11 Pfizer Inc. Heterocyclic 15-substituted-ω-pentanorprostoglandins
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives
IT1088966B (it) * 1977-11-15 1985-06-10 Erba Carlo Spa 13,14-dideidro-prostaglandine
CH656877A5 (de) * 1981-11-27 1986-07-31 Erba Farmitalia Optisch aktive oder racemische prostaglandinderivate.

Also Published As

Publication number Publication date
DK524484D0 (da) 1984-11-02
IT8423390A1 (it) 1986-04-30
ZA848551B (en) 1985-06-26
AU563999B2 (en) 1987-07-30
GR80822B (en) 1985-03-04
AU3494584A (en) 1985-05-09
US4585791A (en) 1986-04-29
DE3439863A1 (de) 1985-05-23
HU193708B (en) 1987-11-30
BE900959A (fr) 1985-05-02
SE8405514D0 (sv) 1984-11-02
JPS60112782A (ja) 1985-06-19
IT8423390A0 (it) 1984-10-30
SE8405514L (sv) 1985-05-05
IT1177095B (it) 1987-08-26
FR2554448A1 (fr) 1985-05-10
GB2149788A (en) 1985-06-19
GB2149788B (en) 1987-04-08
FI844273L (fi) 1985-05-05
GB8329559D0 (en) 1983-12-07
DK524484A (da) 1985-05-05
HUT35637A (en) 1985-07-29
SU1489582A3 (ru) 1989-06-23
CH663413A5 (de) 1987-12-15
IL73395A0 (en) 1985-02-28
FI844273A0 (fi) 1984-10-31
FR2554448B1 (fr) 1987-07-24
GB8427678D0 (en) 1984-12-05

Similar Documents

Publication Publication Date Title
US4359467A (en) Prostanoic acid derivatives and their preparation
NL8403307A (nl) Furylderivaten van op plaats 16 gesubstitueerde prostaglandinen, werkwijze ter bereiding daarvan, alsmede farmaceutisch of veterinair preparaat, dat dergelijke derivaten bevat.
EP2143712A1 (en) Improved Process for the Production of Prostaglandins and Prostaglandin Analogs
GB1601994A (en) Esters of prostan-1-ol derivatives methods for their preparation and compositions containing them
AU2001233286B2 (en) Internal 1,15-lactones of fluprostenol and related prostaglandin F2alpha analogs and their use in the treatment of glaucoma and intraocular hypertension
CH619930A5 (da)
CA1291131C (en) 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8,-inter- m-phenylene pgi _derivatives
US4626597A (en) 16-fluoro-16,17-didehydro prostanoids and process for their preparation
EP1721894A1 (en) Process for the synthesis of prostaglandin derivatives
US3962218A (en) Novel prostanoic acid derivatives and processes for the preparation thereof
US4346228A (en) Novel 11-oxoprostaglandin derivatives
SU976846A3 (ru) Способ получени производных простациклина или их солей
NO852319L (no) Fremgangsmaate for fremstilling av 13-aza-14-okso-txa2-analog-forbindelser.
JP2003321442A (ja) 新規なジフルオロプロスタグランジンアミド誘導体
US4045465A (en) Cyanoprostaglandins
IE45606B1 (en) Prostanoic acid derivatives and processes for their preparation
US4292444A (en) Sulfonyl prostaglandin carboxamide derivatives
CA1087178A (en) 1,3-benzodioxan-prostandic acid derivatives and process for producing them
JPS62209070A (ja) ネオリグナン誘導体
US4070537A (en) 17-Oxo-17-phenyl-prostaglandins
CA1151163A (en) Intermediates for the preparation of prostaglandin analogues
JPS5845420B2 (ja) プロスタグランジン類似化合物およびその製造方法
JPS59144754A (ja) プロスタグランジン類似化合物
JPS6028835B2 (ja) 製造方法
JPH0881454A (ja) C−ヌクレオシド誘導体およびその製法

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BV The patent application has lapsed